Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
07 January 2018 Photo Charl Devenish
Researcher tackling drug-resistant TB through molecular methods
Dr Anneke van der Spoel van Dijk is invested in contributing to the global effort of stopping TB by 2035.

The work of Dr Anneke van der Spoel van Dijk investigates the spread of TB in the Free State population using techniques such as next generation sequencing, spoligotyping and MIRU-VNTR typing. Dr Van der Spoel van Dijk, a senior medical scientist in the Department of Medical Microbiology at the University of the Free State (UFS) also looks at drug resistance in her research. This work informs decisions about how best to treat patients with multidrug-resistant TB (MDR-TB). 

She employs rapid molecular techniques to track one of Africa’s most serious diseases, tuberculosis (TB). 

Drug resistance
Scientists assist the National Health Laboratory Service and Department of Health in trying to refine the diagnostic tools to identify these cases earlier. Dr Van der Spoel van Dijk explains: “Until recently, it took up to two years to fine-tune treatment decisions for patients with MDR-TB. Patients get a cocktail of anti-TB drugs, but it takes time to find the right combination. Re-infection and relapse (patients stopping treatment for several reasons) add to the diagnostic and treatment management challenges.

Enormous impact
“Now doctors can reduce the time needed for diagnostic certainty to about seven days, while new drugs allow reduction of treatment from more than 18 to nine months. This can have an enormous impact on the life of many patients.”

Dr Van der Spoel van Dijk’s work forms part of research in the faculty looking at resistance development in TB strains. She is currently also doing her doctoral thesis on the differences and incidence of MDR-TB among adolescents versus adults. Dr Van der Spoel van Dijk says: “It is a complicated picture, but we hope to unravel it to support better diagnostic tools and patient care.”

As part of the National Health Laboratory Service, her department is playing an important role in TB diagnostics and the training of scientists and future pathologists. “Our work is contributing to the global vision to stop TB by 2035,” Dr Van der Spoel van Dijk says.

News Archive

First Kovsie. First Free Stater. First Female. Prof Driekie Hay makes history.
2014-06-10

 
Prof Driekie Hay, Vice-Rector: Open and Lifelong Innovative Higher Education, was elected to the Board of the Afrikaanse Taal- en Kultuurvereniging (ATKV). It is the first time in the history of the ATKV that someone from our university – as well as from the Free State – has been elected to the Board.

To date, only a few women have been nominated.

“I see this election as recognition of the UFS’s vision to act as a national role player and make a difference through its Human Project and its pursuit of social justice and reconciliation,” says Prof Hay.

She was appointed in the cultural expert portfolio during the ATKV’s Annual General Meeting from 28 to 29 May 2014. In this position Prof Hay has to promote the Afrikaans language and culture on a national level – through an inclusive approach. Prof Hay’s goal is to build bridges between the different language and cultural groups. She would like to establish greater understanding between the various groups in our country. She feels it is important to give shape to “a new generation of South Africans that are no longer threatened by ‘otherness’, but will cherish the treasure of diversity.”

This appointment isn’t only a great honour, but also endorses Prof Hay’s expertise. “On a personal and professional level, this appointment means that they have confidence in my expertise, outlook on life and experience” she says.

Prof Hay will serve on the Board of the ATKV for a three-year term.

The ATKV is a cultural organisation with four main focus areas:

  • language,
  • the arts,
  • communities and
  • education.

 


We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept